ArticleJournal of cell science2026
Microtubule lattice defects facilitate spastin-mediated severing.
Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Towards a systems-level view of the microtubule cytoskeleton and its functions in physiology and disease.Nature reviews. Molecular cell biology · 2026Review
- Microtubule lattice conformation and integrity regulate α-tubulin acetylation.Communications biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The length regulation of microtubules and their organization into complex arrays inside cells occurs through the activity of polymerases and depolymerases, as well as severing enzymes, such as spastin and katanin. Spastin and katanin hexamerize on the microtubule lattice, pull out single tubulin dimers in an ATP-dependent manner and eventually generate internal breaks in the microtubule. Although spastin has been shown to be regulated by post-translational tubulin modifications, the impact of microtubule lattice defects on the severing characteristics of spastin has not been explored. To address this, we prepared GMPCPP-stabilized microtubules with varying defect densities - introduced either through specific polymerization conditions or by end-to-end annealing - for subsequent in vitro severing assays. We found that: (1) the presence of defects accelerated the onset of the severing process; and (2) severing was twice as frequent in microtubule segments with defect sites when compared to random lattice segments. However, there was no evidence of preferential binding of spastin to defect sites. We therefore propose a severing mechanism in which defects do not actively promote microtubule severing but, instead, passively contribute to microtubule lattice instability. The defects thus facilitate the severing process by reducing the number of tubulin subunits that must be removed for severing to occur.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.